"Dose or Strength to be Studied" in ICH M13A [Regulatives / Guidelines]

posted by Darborn – Taiwan, 2024-10-08 02:58 (618 d 13:46 ago) – Posting: # 24223
Views: 3,820

Thanks BEQool for the reply,

I totally agree with your point that a separate paragraph will be needed if it truly means that all high-risk products should be conducting those studies. However, this still needs to be clarified by the authorities. :yes:

Best regard

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
169 visitors (0 registered, 169 guests [including 19 identified bots]).
Forum time: 16:44 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5